These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24823889)

  • 1. Synthesis of a smoothened cholesterol: 18,19-di-nor-cholesterol.
    Mydock-McGrane L; Rath NP; Covey DF
    J Org Chem; 2014 Jun; 79(12):5636-43. PubMed ID: 24823889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol's Condensing Effect: Unpacking a Century-Old Mystery.
    Regen SL
    JACS Au; 2022 Jan; 2(1):84-91. PubMed ID: 35098224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice.
    Suzuki K; Shimizu T; Nakata T
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2133-8. PubMed ID: 9873500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliminating the roughness in cholesterol's β-face: does it matter?
    Krause MR; Wang M; Mydock-McGrane L; Covey DF; Tejada E; Almeida PF; Regen SL
    Langmuir; 2014 Oct; 30(41):12114-8. PubMed ID: 25290635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of cholesterol methyl groups.
    Pöyry S; Róg T; Karttunen M; Vattulainen I
    J Phys Chem B; 2008 Mar; 112(10):2922-9. PubMed ID: 18278902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface occupancy plays a major role in cholesterol's condensing effect.
    Krause MR; Turkyilmaz S; Regen SL
    Langmuir; 2013 Aug; 29(33):10303-6. PubMed ID: 23902525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol's interfacial interactions with galactosylceramides.
    Ali S; Smaby JM; Brockman HL; Brown RE
    Biochemistry; 1994 Mar; 33(10):2900-6. PubMed ID: 8130203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerning the chemical synthesis of 3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one, a novel regulator of cholesterol metabolism.
    Wilson WK; Wang KS; Kisic A; Schroepfer GJ
    Chem Phys Lipids; 1988 Sep; 48(1-2):7-17. PubMed ID: 3208416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of sterol synthesis. Metabolism-based design and construction of a new analog of 3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one and its effects in cultured mammalian cells and in rats.
    Swaminathan S; Siddiqui AU; Gerst N; Pinkerton FD; Kisic A; Kim LJ; Wilson WK; Schroepfer GJ
    J Lipid Res; 1995 Apr; 36(4):767-86. PubMed ID: 7616123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol's aliphatic side chain modulates membrane properties.
    Scheidt HA; Meyer T; Nikolaus J; Baek DJ; Haralampiev I; Thomas L; Bittman R; Müller P; Herrmann A; Huster D
    Angew Chem Int Ed Engl; 2013 Dec; 52(49):12848-51. PubMed ID: 24382636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of sterol synthesis. Chemical synthesis and properties of 3 beta-hydroxy-25,26,26,26,27,27,27-heptafluoro-5 alpha-cholest-8(14)-en-15-one and 25,26,26,26,27,27,27-heptafluorocholesterol and their effects on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured mammalian cells.
    Swaminathan S; Wilson WK; Pinkerton FD; Gerst N; Ramser M; Schroepfer GJ
    J Lipid Res; 1993 Oct; 34(10):1805-23. PubMed ID: 8245728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of sterol synthesis. Synthesis and spectral properties of 3 beta-hydroxy-25,26,26,26,27,27,27-heptafluoro-5 alpha-cholestan-15-one.
    Siddiqui AU; Swaminathan S; Su X; Wilson WK; Schroepfer GJ
    Chem Phys Lipids; 1997 Apr; 86(2):95-119. PubMed ID: 9179993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol's interfacial interactions with sphingomyelins and phosphatidylcholines: hydrocarbon chain structure determines the magnitude of condensation.
    Smaby JM; Brockman HL; Brown RE
    Biochemistry; 1994 Aug; 33(31):9135-42. PubMed ID: 8049216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol-binding site of the influenza M2 protein in lipid bilayers from solid-state NMR.
    Elkins MR; Williams JK; Gelenter MD; Dai P; Kwon B; Sergeyev IV; Pentelute BL; Hong M
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):12946-12951. PubMed ID: 29158386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of OSW-1 derivatives by site-selective acylation and their biological evaluation.
    Sakurai K; Takeshita T; Hiraizumi M; Yamada R
    Org Lett; 2014 Dec; 16(24):6318-21. PubMed ID: 25490062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A total synthesis of OSW-1.
    Xue J; Liu P; Pan Y; Guo Z
    J Org Chem; 2008 Jan; 73(1):157-61. PubMed ID: 18067313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New analogues of the potent cytotoxic saponin OSW-1.
    Wojtkielewicz A; Długosz M; Maj J; Morzycki JW; Nowakowski M; Renkiewicz J; Strnad M; Swaczynová J; Wilczewska AZ; Wójcik J
    J Med Chem; 2007 Jul; 50(15):3667-73. PubMed ID: 17608396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol's location in lipid bilayers.
    Marquardt D; Kučerka N; Wassall SR; Harroun TA; Katsaras J
    Chem Phys Lipids; 2016 Sep; 199():17-25. PubMed ID: 27056099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin of cholesterol's condensing effect.
    Daly TA; Wang M; Regen SL
    Langmuir; 2011 Mar; 27(6):2159-61. PubMed ID: 21319766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of Stereoisomers by Their Enantioselective Interactions with Chiral Cholesterol-Containing Membranes.
    Tsuchiya H; Mizogami M
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29295605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.